Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionWELLS FARGO VARIABLE TRUST - Wells Fargo VT Index Asset Allocation Fund Class 2
Latest Disclosed Ownership977 shares
Latest Disclosed Value $ 108,319
WELLS FARGO VARIABLE TRUST - Wells Fargo VT Index Asset Allocation Fund Class 2 reports 4.68% decrease in ownership of GILD / Gilead Sciences, Inc.

On August 26, 2025 - WELLS FARGO VARIABLE TRUST - Wells Fargo VT Index Asset Allocation Fund Class 2 filed a NPORT-P form disclosing ownership of 977 shares of Gilead Sciences, Inc. (US:GILD) valued at $108,320 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 27, 2025 disclosing 1,025 shares of Gilead Sciences, Inc.. This represents a change in shares of -4.68% during the quarter. The current value of the position is $126,033 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Gilead Sciences EC US3755581036 977 -48 -4.68 108 -5.26 0.1596
2025-05-27 2025-03-31 NP Gilead Sciences EC US3755581036 1,025 -32 -3.03 115 17.53 0.1731
2025-02-26 2024-12-31 NP Gilead Sciences EC US3755581036 1,057 -67 -5.96 98 3.19 0.1397
2024-11-25 2024-09-30 NP Gilead Sciences EC US3755581036 1,124 -31 -2.68 94 18.99 0.1300
2024-08-26 2024-06-30 NP Gilead Sciences EC US3755581036 1,155 -28 -2.37 79 -8.14 0.1135
2024-05-28 2024-03-31 NP Gilead Sciences EC US3755581036 1,183 -64 -5.13 87 -14.85 0.1242
2024-02-28 2023-12-31 NP Gilead Sciences EC US3755581036 1,247 -30 -2.35 101 6.32 0.1515
2023-11-22 2023-09-30 NP Gilead Sciences EC US3755581036 1,277 -148 -10.39 96 -12.84 0.1539
2023-08-28 2023-06-30 NP Gilead Sciences EC US3755581036 1,425 7 0.49 110 -6.84 0.1657
2023-05-25 2023-03-31 NP Gilead Sciences EC US3755581036 1,418 -37 -2.54 118 -5.65 0.1824
2023-02-24 2022-12-31 NP Gilead Sciences EC US3755581036 1,455 -26 -1.76 125 36.26 0.1997
2022-11-29 2022-09-30 NP GILEAD SCIENCES INC USD.001 EC US3755581036 1,481 -38 -2.50 91 -2.15 0.1491
2022-08-29 2022-06-30 NP GILEAD SCIENCES INC USD.001 EC US3755581036 1,519 -32 -2.06 94 1.09 0.1429
2022-05-31 2022-03-31 NP GILEAD SCIENCES INC USD.001 EC US3755581036 1,551 -44 -2.76 92 -20.00 0.1207
2022-02-28 2021-12-31 NP GILEAD SCIENCES INC USD.001 EC US3755581036 1,595 -57 -3.45 116 0.00 0.1393
2021-11-24 2021-09-30 NP GILEAD SCIENCES INC USD.001 EC US3755581036 1,652 -72 -4.18 115 -2.54 0.1434
2021-08-27 2021-06-30 NP GILEAD SCIENCES INC USD.001 EC US3755581036 1,724 -97 -5.33 119 0.85 0.1448
2021-06-01 2021-03-31 NP GILEAD SCIENCES INC USD.001 EC US3755581036 1,821 -98 -5.11 118 5.41 0.1484
2021-03-01 2020-12-31 NP GILEAD SCIENCES INC USD.001 EC US3755581036 1,919 -120 -5.89 112 -13.28 0.1419
2020-11-25 2020-09-30 NP GILEAD SCIENCES INC USD.001 EC US3755581036 2,039 -82 -3.87 129 -21.47 0.1729
2020-08-28 2020-06-30 NP GILEAD SCIENCES INC USD.001 EC US3755581036 2,121 84 4.12 163 7.24 0.2291
2020-05-28 2020-03-31 NP GILEAD SCIENCES INC USD.001 EC US3755581036 2,037 -45 -2.16 152 12.59 0.2383
2020-02-28 2019-12-31 NP GILEAD SCIENCES INC USD.001 EC 375558103 2,082 -133 -6.00 135 -3.57 0.1873
2019-11-26 2019-09-30 NP GILEAD SCIENCES INC USD.001 EC US3755581036 2,215 2,215 140 0.1944
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.